MetaADEDB 2.0 @ LMMD
Levoflaxacin
(HSVIINWFPKEOEQ-NSHDSACASA-N)
Structure
SMILES
COC(=O)c1cn2[C@@H](C)COc3c2c(c1=O)cc(c3N1CCN(CC1)C)F
Molecular Formula:
C19H22FN3O4
Molecular Weight:
375.394
Log P:
1.6353
Hydrogen Bond Acceptor:
7
Hydrogen Bond Donor:
0
TPSA:
64.01
CAS Number(s):
862690-19-5
Synonym(s)
1.
Levoflaxacin
External Link(s)
PubChem Compound44326612
BindingDB50131445
ZINC26666727
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1PainFAERS: 2US FAERS
2Acute psychosisFAERS: 1US FAERS
3AngioedemaFAERS: 1US FAERS
4AnxietyFAERS: 1US FAERS
5Burning sensationFAERS: 1US FAERS
6ChokingFAERS: 1US FAERS
7DiscomfortFAERS: 1US FAERS
8FatigueFAERS: 1US FAERS
9Gait inabilityFAERS: 1US FAERS
10HypotensionFAERS: 1US FAERS
11Lip swellingFAERS: 1US FAERS
12MalaiseFAERS: 1US FAERS
13Memory impairmentFAERS: 1US FAERS
14Mood swingsFAERS: 1US FAERS
15Musculoskeletal PainFAERS: 1US FAERS
16NeuralgiaFAERS: 1US FAERS
17Oral fungal infectionFAERS: 1US FAERS
18Postural Orthostatic Tachycardia SyndromeFAERS: 1US FAERS
19Product quality issueFAERS: 1US FAERS
20PruritusFAERS: 1US FAERS
21Psychiatric symptomFAERS: 1US FAERS
22Toxicity to various agentsFAERS: 1US FAERS
23UrticariaFAERS: 1US FAERS
24Weight decreasedFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120269

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.